PRANA BIOTECHNOLOGY LTD's ticker is PRANXXXX and the CUSIP is 739727105. A total of 1 filers reported holding PRANA BIOTECHNOLOGY LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $70,000 | +48.9% | 15,551 | -6.1% | 0.07% | +20.0% |
| Q1 2016 | $47,000 | -34.7% | 16,555 | -83.3% | 0.06% | -32.1% |
| Q4 2015 | $72,000 | -26.5% | 99,342 | -9.1% | 0.08% | -25.0% |
| Q3 2015 | $98,000 | -23.4% | 109,342 | 0.0% | 0.11% | -13.6% |
| Q2 2015 | $128,000 | +4.9% | 109,342 | 0.0% | 0.12% | +9.6% |
| Q1 2015 | $122,000 | -32.2% | 109,342 | -0.5% | 0.11% | -30.1% |
| Q4 2014 | $180,000 | -33.3% | 109,842 | -13.1% | 0.16% | -39.6% |
| Q3 2014 | $270,000 | -7.8% | 126,342 | -2.3% | 0.27% | -1.1% |
| Q2 2014 | $293,000 | -22.5% | 129,342 | -4.1% | 0.27% | -25.0% |
| Q1 2014 | $378,000 | -58.0% | 134,842 | +5.1% | 0.36% | -57.1% |
| Q4 2013 | $899,000 | +117.1% | 128,283 | +27.3% | 0.85% | +100.2% |
| Q3 2013 | $414,000 | +108.0% | 100,783 | +17.5% | 0.42% | +98.1% |
| Q2 2013 | $199,000 | – | 85,783 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GARRISON BRADFORD & ASSOCIATES INC | 129,342 | $293,000 | 0.27% |
| Columbia Asset Management | 64,150 | $145,000 | 0.06% |
| RA Capital Management | 100,000 | $227,000 | 0.02% |
| Verition Fund Management LLC | 52,856 | $119,000 | 0.01% |
| B. Riley Wealth Management, Inc. | 8,090 | $18,000 | 0.01% |
| JANE STREET GROUP, LLC | 128,660 | $291,000 | 0.00% |
| Nine Chapters Capital Management LLC | 15,900 | $36,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 58,238 | $132,000 | 0.00% |
| Aperio Group, LLC | 17,127 | $39,000 | 0.00% |
| COLONY GROUP LLC | 1,600 | $4,000 | 0.00% |